2025 MCM | New and Evolving Directions in the Treatment of HER2 Positive Breast Cancer
Overview
NA
Target Audience
Physicians
Nurses
Pharmacists
Physician Associates
This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.
Faculty
Mark Pegram, MD
Date of Release
June 24th, 2025
-1762971835839.webp&w=3840&q=75)
-1762971661880.webp&w=3840&q=75)